Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Astellas Pharma US Inc. recalls Prograf (tacrolimus) capsules

Class Iofficial

FDA Class I

FDA classified this recall as Class I: the most serious kind, meaning there is a reasonable chance the product could cause serious health problems or death.

Hazard
Failed Tablet/Capsule Specifications: Bottles shipped to the USA may contain empty capsules
Products
  • Prograf (tacrolimus) capsules
Where it was sold

Nationwide in the USA

Nationwide

Units affected
14,340 100-count bottles
About this recall
Prograf (tacrolimus) capsules, USP, 0.5 mg, 100-count bottle, Rx Only, Product of Japan, Distributed by: Astellas Pharma US, Inc., Northbrook, IL 60062, NDC 0469-0607-73.